CareDx, Inc. (CDNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 200M 400M 600M Q3 '21: 275.8M Q4 '21: 296.4M Q1 '22: 308.4M Q2 '22: 314.9M Q3 '22: 318.6M Q4 '22: 321.8M Q1 '23: 319.6M Q2 '23: 309.3M Q3 '23: 297.1M Q4 '23: 280.3M Q1 '24: 275.1M Q2 '24: 297.1M Q3 '24: 312.8M Q4 '24: 333.8M Q1 '25: 346.4M Q2 '25: 340.8M Q3 '25: 358M Q4 '25: 379.8M Q1 '26: 412.8M Q2 '26: 458.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 35M 70M 105M Q4 '18: 43.6M Q1 '19: 52.2M Q2 '19: 61.5M Q3 '19: 71.5M Q4 '19: 81.6M Q1 '20: 91.4M Q2 '20: 98.2M Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20

Operating Income TTM

-210M -140M -70M 0 70M 140M 210M Q3 '20: -25M Q4 '20: -22.5M Q1 '21: -17.6M Q2 '21: -11.6M Q3 '21: -17.4M Q4 '21: -29.7M Q1 '22: -47.9M Q2 '22: -64.9M Q3 '22: -73.5M Q4 '22: -77.2M Q1 '23: -82.5M Q2 '23: -88.4M Q3 '23: -99.9M Q4 '23: -203.4M Q1 '24: -201.6M Q2 '24: -181.3M Q3 '24: -166.2M Q4 '25: -30.8M Q1 '26: -16.2M Q2 '26: 108.1M Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '26

Net Income TTM

-210M -140M -70M 0 70M 140M 210M Q3 '21: -18M Q4 '21: -30.7M Q1 '22: -49.6M Q2 '22: -69.4M Q3 '22: -74.4M Q4 '22: -76.6M Q1 '23: -80.7M Q2 '23: -84M Q3 '23: -90.5M Q4 '23: -190.3M Q1 '24: -186.4M Q2 '24: -166.1M Q3 '24: -153.2M Q4 '24: 52.5M Q1 '25: 62.1M Q2 '25: 58.1M Q3 '25: 70.5M Q4 '25: -21.4M Q1 '26: -8.2M Q2 '26: 111M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 20M 40M 60M Q4 '18: 33M Q1 '19: 36.3M Q2 '19: 40.6M Q3 '19: 43.2M Q4 '19: 45.5M Q1 '20: 48.1M Q2 '20: 51.6M Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20

Operating Cash Flow TTM

-35M 0 35M 70M 105M Q3 '21: -16.3M Q4 '21: -19.3M Q1 '22: -7.1M Q2 '22: -20.8M Q3 '22: -28.3M Q4 '22: -25.2M Q1 '23: -3.1M Q2 '23: 278K Q3 '23: -2.8M Q4 '23: -18.4M Q1 '24: -34.4M Q2 '24: -14.9M Q3 '24: 7.8M Q4 '24: 38M Q1 '25: 26.8M Q2 '25: 17.7M Q3 '25: 42.6M Q4 '25: 42M Q1 '26: 72.9M Q2 '26: 93.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q4 '14: -4.1M Q1 '15: -5.6M Q2 '15: -8.4M Q3 '15: -8M Q4 '15: -11M Q1 '16: -15.9M Q2 '16: -20M Q3 '16: -18.1M Q4 '17: -14.5M Q1 '18: -12.3M Q2 '18: -11.3M Q3 '18: -9.3M Q4 '18: -6M Q1 '19: -7.9M Q2 '19: -2M Q3 '19: -1.6M Q1 '15 Q3 '15 Q1 '16 Q3 '16 Q1 '18 Q3 '18 Q1 '19 Q3 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 42.8M Q2 '20: 44.7M Q3 '20: 49M Q1 '21: 51.2M Q2 '21: 52.2M Q3 '21: 52.7M Q1 '22: 53M Q2 '22: 53.2M Q3 '22: 53.5M Q1 '23: 53.6M Q2 '23: 53.8M Q3 '23: 54.2M Q1 '24: 51.7M Q2 '24: 52.2M Q3 '24: 52.9M Q1 '25: 55.3M Q2 '25: 54.3M Q3 '25: 53.7M Q1 '26: 53.1M Q2 '26: 53.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -0.35 Q4 '21: -0.59 Q1 '22: -0.95 Q2 '22: -1.32 Q3 '22: -1.41 Q4 '22: -1.45 Q1 '23: -1.52 Q2 '23: -1.57 Q3 '23: -1.68 Q4 '23: -3.53 Q1 '24: -3.47 Q2 '24: -3.10 Q3 '24: -2.87 Q4 '24: 0.93 Q1 '25: 1.12 Q2 '25: 1.05 Q3 '25: 1.28 Q4 '25: -0.40 Q1 '26: -0.16 Q2 '26: 2.07 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.